Skip to main content

Advertisement

Log in

Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer Disease

  • Research Article
  • Theme: Advanced Technologies for Oral Controlled Release
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The aim of this study was to develop a taste-masked oral disintegrating film (ODF) containing donepezil, with fast disintegration time and suitable mechanical strength, for the treatment of Alzheimer’s disease. Hydroxypropyl methylcellulose, corn starch, polyethylene glycol, lactose monohydrate and crosspovidone served as the hydrophilic polymeric bases of the ODF. The uniformity, in vitro disintegration time, drug release and the folding endurance of the ODF were examined. The in vitro results showed that 80% of donepezil hydrochloride was released within 5 minutes with mean disintegration time of 44 seconds. The result of the film flexibility test showed that the number of folding time to crack the film was 40 times, an indication of sufficient mechanical property for patient use. A single-dose, fasting, four-period, eight-treatment, double-blind study involving 16 healthy adult volunteers was performed to evaluate the in situ disintegration time and palatability of ODF. Five parameters, namely taste, aftertaste, mouthfeel, ease of handling and acceptance were evaluated. The mean in situ disintegration time of ODF was 49 seconds. ODF containing 7 mg of sucralose were more superior than saccharin and aspartame in terms of taste, aftertaste, mouthfeel and acceptance. Furthermore, the ODF was stable for at least 6 months when stored at 40°C and 75% relative humidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

REFERENCES

  1. Joseph TD, Robert LT, Gary CY, Gary RM, Barbara GW, Michael LP. Pharmacotherapy: a pathophysiologic approach. 6th ed. New York: McGraw Hill; 2005. p. 2162–87.

    Google Scholar 

  2. Martin RF. Effective pharmacologic management of Alzheimer disease. AJM. 2007;120:388–97.

    Article  Google Scholar 

  3. Hanawa T. Development of a new and kindly oral dosage form for elderly. JPST. 1997;13:251–8.

    CAS  Google Scholar 

  4. Yamamoto Y, Fujii M, Watanabe K, Tsukamoto M, Shibata Y, Kondoh M, et al. Effect of powder characteristics on oral tablet disintegration. Int J Pharm. 2009;365:116–20.

    Article  PubMed  CAS  Google Scholar 

  5. Sunada H, Bi YX. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol. 2002;122:188–98.

    Article  CAS  Google Scholar 

  6. Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier Jp, Piccerelle Ph. Determination of the in-vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005;292:29–41.

    Article  PubMed  CAS  Google Scholar 

  7. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139:94–107.

    Article  PubMed  CAS  Google Scholar 

  8. Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations in formulation and technology. Recent Patents on Drug Delivery and Formulation. 2008;2:258.

    Article  PubMed  CAS  Google Scholar 

  9. Mishra R, Amin A. Formulation development of taste-masked rapidly dissolving films of cetirizine hydrochloride. Pharmtech. 2009;33(2):48–56.

    CAS  Google Scholar 

  10. Pillai R, Karatgi P. Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle management. Pharmtech Europe. 2009;21(5):37–41.

    Google Scholar 

  11. Shimoda H, Taniguchi K, Nishimura M, Matsuura K, Tsukioka T, Yamashita H, et al. Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Eur J Pharm Sci. 2009;73:361–5.

    CAS  Google Scholar 

  12. Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm. 2009;368:98–102.

    Article  PubMed  CAS  Google Scholar 

  13. Chambin O, Champion D, Debray C, Rochat-Gonthier MH, Le Meste M, Pourcelot Y. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J Control Release. 2004;95:101–8.

    Article  PubMed  CAS  Google Scholar 

  14. Yan YD, Jong SW, Kang JH, Yong CS, Choi HG. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Biol Pharm Bull. 2010;33(8):1364–70.

    Article  PubMed  CAS  Google Scholar 

  15. Borsadia SB, O'Halloran D, Osborne JL. Quick-dissolving films—a novel approach to drug delivery. Drug development and delivery. 2003;3(3). Available online at http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=&nm=&type=Publishing&mod=Publications%3A%3AArticle&mid=8F3A7027421841978F18BE895F87F791&tier=4&id=1462E9E570724362AF256AB9CEC63126.

  16. Koh N, Sakamoto S, Chino F. Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet. Tohoku J Exp Med. 2008;216(3):249–57.

    Article  PubMed  Google Scholar 

  17. Bruce JK, Angela LH, Liu H, Sara KW. Olanzapine orally disintegrating tablet in the treatment of acutely ill non-compliant patients with schizophrenia. IJNP. 2003;6:97–102.

    Google Scholar 

  18. Raviraj P, Pradeep K. Orally disintegrating tablets: the path to improve patient compliance and enhanced life cycle management. Pharmtech Europe. 2009;21:5.

    Google Scholar 

  19. Emilio MC, Vincente GG, Albert NS, Jose PF, Joan HN, Jordi GC, et al. A study on the subjective compliance and acceptance of oral lanzoprazole in traumatology. The ECOFT-TR Study. Clin Rheumatol. 2009;5(2):49–54.

    Google Scholar 

  20. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note. AAPS PharmSciTech. 2007;8(1):13.

    Article  PubMed  Google Scholar 

  21. Mishra R, Amin A. Manufacturing techniques of orally dissolving films. J Pharm Sci. 2011;35(1):70–3.

    Google Scholar 

  22. Pappa H, Farrú R, Vilanova PO, Palacios M, Pizzorno MT. A new HPLC method to determine donepezil hydrochloride in tablets. J Pharmaceut Biomed. 2002;27:177–82.

    Article  CAS  Google Scholar 

  23. Japanese Pharmacopoeia 15. General tests, processes and apparatus. Tokyo, Japan: The Society of Japanese Pharmacopoeia. p. 107.

  24. Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm. 2008;70(3):895–900.

    Article  PubMed  CAS  Google Scholar 

  25. Kuno Y, Kojima M, Andoand S, Nakagami H. Effect of preparation method on properties of orally disintegrating tablets made by phase transition. Int J Pharm. 2008;355(1–2):87–92.

    Article  PubMed  CAS  Google Scholar 

  26. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 702.

    Google Scholar 

  27. Doe J. 2010 Sucralose—Technological Justification. www.food.gov.uk/multimedia/pdfs/sucraconsult2.pdf. Accessed26 Oct 2010.

  28. Rowe R, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 48.

    Google Scholar 

  29. Bayarri S, Izquierdo L, Costell E. Sweetening power of aspartame in hydrocolloids gels: influence of texture. Food Hydrocolloids. 2007;21:1265–74.

    Article  CAS  Google Scholar 

  30. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009.

    Google Scholar 

  31. Riera CE, Vogel H, Simon SA, Coutre Jl. Artificial sweeteners and salts producing a metallic taste sensation activate TRPV1 receptors. Am J Physiol. 2007;293:626–34.

    Google Scholar 

  32. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. A new formulation for orally disintegrating tablets using a suspension spray-coating method. Int J Pharm. 2009;382(1–2):80–7.

    Article  PubMed  CAS  Google Scholar 

  33. Chandrasekhar R, Hassan Z, AlHusban F, Smith AM, Mohammed AR. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Eur J Pharm Biopharm. 2009;72:119–29.

    Article  PubMed  CAS  Google Scholar 

  34. Kearney P, Rathbone MJ, Hadgraft R. The Zydis oral fast-dissolving dosage form. Modified-Release Drug Delivery Technology. 2002;2:191–201.

    Google Scholar 

  35. Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle Ph. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm. 2004;278:423–33.

    Article  PubMed  CAS  Google Scholar 

  36. Park TJ, Ko DH, Kim YJ, Kim YG. Polymorphic characterization of pharmaceutical solids, donepezil hydrochloride, by C CP/MAS solid-state nuclear magnetic resonance spectroscopy. B Kor Chem Soc. 2009;30(9):2007–10.

    Article  CAS  Google Scholar 

  37. Krishna R, Moses JB, Anil K, Chandrashekar, Vijayavitthal T, Eswaraiah S, et al. Identification and characterization of potential impurities of donepezil. J Pharmaceut Biomed. 2004;35(5):1047–58.

    Article  Google Scholar 

Download references

ACKNOWLEDGEMENT

This author would like to thank Institute of Postgraduate Studies, Universiti Sains Malaysia for providing Fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kok Khiang Peh.

Additional information

Guest Editors: Michael Repka, Joseph Reo, Linda Felton, and Stephen Howard

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liew, K.B., Tan, Y.T.F. & Peh, K.K. Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer Disease. AAPS PharmSciTech 13, 134–142 (2012). https://doi.org/10.1208/s12249-011-9729-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-011-9729-4

KEY WORDS

Navigation